Atrial fibrillation as a prognostic factor for all-cause mortality in patients with transthyretin amyloid cardiomyopathy

被引：0
|
作者：
Witteles, R. [1 ]
Sultan, M. B. [2 ]
Gundapaneni, B. [3 ]
Garcia-Pavia, P. [4 ,5 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Inc, Groton, CT USA
[4] Hosp Univ Puerta Hierro Majadahonda, CIBERCV, Madrid, Spain
[5] Univ Francisco Vitoria, Madrid, Spain
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：861 / 861
页数：1
相关论文
共 50 条
  • [41] Impact of age on the association between body mass index and all-cause mortality in patients with atrial fibrillation
    Wu, S.
    Yang, Y-M
    Zhu, J.
    Wan, H-B
    Wang, J.
    Zhang, H.
    Shao, X-H
    JOURNAL OF NUTRITION HEALTH & AGING, 2017, 21 (10): : 1125 - 1132
  • [42] Impact of frailty on all-cause mortality and major bleeding in patients with atrial fibrillation: A meta-analysis
    He, Lian
    He, Rong
    Huang, Jiabin
    Zou, Chen
    Fan, Yu
    AGEING RESEARCH REVIEWS, 2022, 73
  • [43] Trends in all-cause mortality of atrial fibrillation in hospitalized patients in Sweden between 1995-2008
    Sztaniszlav, A.
    Magnuson, A.
    Bryngelsson, I. L.
    Edvardsson, N.
    Sztaniszlav, K.
    Poci, D.
    EUROPEAN HEART JOURNAL, 2021, 42 : 296 - 296
  • [44] Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
    Pokorney, Sean D.
    Piccini, Jonathan P.
    Stevens, Susanna R.
    Patel, Manesh R.
    Pieper, Karen S.
    Halperin, Jonathan L.
    Breithardt, Gunter
    Singer, Daniel E.
    Hankey, Graeme J.
    Hacke, Werner
    Becker, Richard C.
    Berkowitz, Scott D.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Fox, Keith A. A.
    Califf, Robert M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (03):
  • [45] Left atrial size and the risk of long-term all-cause mortality in patients with atrial fibrillation and heart failure
    Ren, J. M. Jiameng
    Wu, S.
    Yang, Y. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 118 - 119
  • [46] Atrial fibrillation, venous thromboembolism, ischemic stroke, and all-cause mortality: The Tromso study
    Hald, Erin Mathiesen
    Lochen, Maja-Lisa
    Mathiesen, Ellisiv B.
    Wilsgaard, Tom
    Njolstad, Inger
    Braekkan, Sigrid K.
    Hansen, John-Bjarne
    Cannegieter, Suzanne
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (06) : 1004 - 1012
  • [47] Atrial Fibrillation Independently Increases Risk of All-Cause Mortality: The Honolulu Heart Program
    Rivera, Kahealanik K.
    CIRCULATION, 2012, 126 (21)
  • [48] Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathy
    Oike, Fumi
    Usuku, Hiroki
    Yamamoto, Eiichiro
    Yamada, Toshihiro
    Egashira, Koichi
    Morioka, Mami
    Nishi, Masato
    Komorita, Takashi
    Hirakawa, Kyoko
    Tabata, Noriaki
    Yamanaga, Kenshi
    Fujisue, Koichiro
    Hanatani, Shinsuke
    Sueta, Daisuke
    Arima, Yuichiro
    Araki, Satoshi
    Takashio, Seiji
    Oda, Seitaro
    Misumi, Yohei
    Kawano, Hiroaki
    Matsushita, Kenichi
    Ueda, Mitsuharu
    Matsui, Hirotaka
    Tsujita, Kenichi
    ESC HEART FAILURE, 2022, 8 (06): : 5316 - 5326
  • [49] Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathy
    Oike, Fumi
    Usuku, Hiroki
    Yamamoto, Eiichiro
    Yamada, Toshihiro
    Egashira, Koichi
    Morioka, Mami
    Nishi, Masato
    Komorita, Takashi
    Hirakawa, Kyoko
    Tabata, Noriaki
    Yamanaga, Kenshi
    Fujisue, Koichiro
    Hanatani, Shinsuke
    Sueta, Daisuke
    Arima, Yuichiro
    Araki, Satoshi
    Takashio, Seiji
    Oda, Seitaro
    Misumi, Yohei
    Kawano, Hiroaki
    Matsushita, Kenichi
    Ueda, Mitsuharu
    Matsui, Hirotaka
    Tsujita, Kenichi
    ESC HEART FAILURE, 2021, 8 (06): : 5316 - 5326
  • [50] Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy How Worried Should We Get?
    Fine, Nowell M.
    JACC: CARDIOONCOLOGY, 2024, 6 (04): : 599 - 601
12345